Mekinist

Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
Endpoints
Novartis
Tafinlar
Mekinist
pediatric
brain cancer
FDA
Flag link:
Genuv Cancer Drug Shows Early Potential in Alzheimer's
Genuv Cancer Drug Shows Early Potential in Alzheimer's
BioSpace
Genuv
Alzheimer's disease
Mekinist
Flag link:
Novartis Combo could be New Standard of Care for Pediatric Glioma Patients
Novartis Combo could be New Standard of Care for Pediatric Glioma Patients
BioSpace
Novartis
Tafinlar
Mekinist
pediatric
clinical trials
glioma
ASCO 2022
Flag link:
FDA approves Novartis combo therapy for aggressive type of thyroid cancer
FDA approves Novartis combo therapy for aggressive type of thyroid cancer
Reuters
Novartis
FDA
Tafinlar
Mekinist
anaplastic thyroid cancer
Flag link:
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Endpoints
FDA
Novartis
Tafinlar
Mekinist
non-small cell lung cancer
Flag link:
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Fierce Pharma
Novartis
FDA
Tafinlar
Mekinist
non-small cell lung cancer
BRAF V600
Flag link:
Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer
Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer
Fierce Pharma
Novartis
Europe
Tafinlar
Mekinist
lung cancer
BRAF V600
Flag link:
Novartis' Lung Cancer Drug Combo Gets EU Nod
Novartis' Lung Cancer Drug Combo Gets EU Nod
Investopedia
Novartis
Europe
metastatic non-small cell lung cancer
Tafinlar
Mekinist
Flag link:
Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK
Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK
Fierce Pharma
Novartis
Europe
melanoma
GSK
Mekinist
Tafinlar
Flag link:
Novartis melanoma drug combination wins EU green light
Novartis melanoma drug combination wins EU green light
Yahoo/Reuters
Novartis
melanoma
Europe
Mekinist
Tafinlar
GSK
Flag link:
Post-swap Novartis preps cancer drug R&D road show
Post-swap Novartis preps cancer drug R&D road show
Fierce Biotech
Novartis
R&D
cancer
Tafinlar
Mekinist
GSK
ASCO
Flag link:
Clovis taps GlaxoSmithKline to team up on lung cancer
Clovis taps GlaxoSmithKline to team up on lung cancer
Fierce Biotech
Clovis
GSK
non-small cell lung cancer
Mekinist
rociletinib
Flag link:
Study: GlaxoSmithKline's Mekinist, Tafinlar combination shows survival benefit versus Roche's Zelboraf in melanoma
Study: GlaxoSmithKline's Mekinist, Tafinlar combination shows survival benefit versus Roche's Zelboraf in melanoma
First Word Pharma
GSK
Mekinist
Tafinlar
Zelboraf
melanoma
Flag link:
EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar
EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar
Yahoo/Reuters
GSK
melanoma
Europe
Bayer
Nexavar
Mekinist
thyroid cancer
Flag link:
GSK melanoma drug combination faces delay in Europe
GSK melanoma drug combination faces delay in Europe
Yahoo/Reuters
GSK
Europe
melanoma
Mekinist
Tafinlar
Flag link:
GlaxoSmithKline and Personalized Medicine Take Another Leap Forward
GlaxoSmithKline and Personalized Medicine Take Another Leap Forward
Motley Fool
GSK
personalized medicine
melanoma
Tafinlar
Mekinist
Merck
Flag link:
GSK says melanoma combination meets main goal
GSK says melanoma combination meets main goal
Reuters
GSK
Tafinlar
Mekinist
melanoma
Flag link:
GSK melanoma drug combination wins accelerated U.S. approval
GSK melanoma drug combination wins accelerated U.S. approval
Yahoo/Reuters
GSK
FDA
Tafinlar
Mekinist
melanoma
Flag link:
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
Flag link:
3 Orphan Drugmakers to Watch
3 Orphan Drugmakers to Watch
Motley Fool
orphan drugs
Biomarin
GSK
Vimizim
Tafinlar
Mekinist
Myozyme
Cerazyme
Sanofi
Flag link:

Pages